Sign in to view Alan’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Alan’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Saddle River, New Jersey, United States
Sign in to view Alan’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
6K followers
500+ connections
Sign in to view Alan’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Alan
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Alan
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Alan’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Activity
6K followers
-
Alan Mateo reposted thisAlan Mateo reposted thisVeeva AI will be ready for general availability sooner than planned! Thanks to the team's excellent progress, Veeva AI for commercial, including #VaultCRM, is planned for release this December followed by all other areas in 2026. With Veeva AI we are adding agentic AI into the Vault Platform, developing deep, specific AI agents in each application, and giving customers the ability to create custom agents that run inside the Vault Platform. #VeevaAI a big step that can have a major impact on #lifesciences productivity and innovation. See the news https://lnkd.in/gNH3sMGc Veeva Systems
-
Alan Mateo shared thisErik Smith is #hiring. Know anyone who might be interested?
-
Alan Mateo shared thisStudy Migration - I have been in the industry almost 20 years and this has always been the holy grail to enable sponsors to make a change. Congrats to the team for making it possible.Alan Mateo shared thisI am very excited to share this news. This is a major step forward for our industry and demonstrates just how real and possible it is to migrate studies, even larger studies with more than 500 sites and 7,000 patients, to a new system with minimal disruption. Thank you to our customers who challenge us each and every day - you motivate us to continue pushing the boundaries for #clinicaldatamanagement. Read the full story here: https://bit.ly/3vAF9MjVeeva Completes Study Migrations to Veeva Vault EDC for Top Biopharma | VeevaVeeva Completes Study Migrations to Veeva Vault EDC for Top Biopharma | Veeva
-
Alan Mateo shared thisAlan Mateo shared thisToday I posted this Medium article sharing learnings and progress since Veeva became a #publicbenefitcorporation over two years ago. Our annual PBC report, which details key decisions as we build for the long term, may also be helpful to understand our early experience. https://lnkd.in/g_QmSSFB
-
Alan Mateo shared thisCourt Rejects Medidata Lawsuit Against Veeva for Lack of Blocks Medidata's Moves to Limit Competition and Employee Rights. https://lnkd.in/evJ4RYRz These days with news headlines of inflation, war and Covid its hard to stay optimistic but then something happens closer to home to restores your faith in the system and the future. In 2017, Many unsubstantiated accusations and claims against Veeva and employees. On July 15th ,Federal court rejected Medidata's lawsuit. Here is the press release with the detail. Enjoy the read !!Court Rejects Medidata Lawsuit Against Veeva for Lack of Evidence, Blocks Medidata’s Moves to Limit Competition and Employee Rights | VeevaCourt Rejects Medidata Lawsuit Against Veeva for Lack of Evidence, Blocks Medidata’s Moves to Limit Competition and Employee Rights | Veeva
-
Alan Mateo shared thisDave is build a great team at Veeva.Alan Mateo shared thisDoes being the CEO of your own account and selling innovative market-leading cloud products sound exciting to you? We're looking for Enterprise Account Partners with consulting experience in Drug Development to lead our top accounts. Every day our team partners closely with global leaders of the world's top pharma companies to help bring medicines and therapies to patients faster. Click here to learn more: https://bit.ly/3K5490C and Clinical https://bit.ly/3iTO41N.
-
Alan Mateo shared thisRichard Young is #hiring. Know anyone who might be interested?
-
Alan Mateo reacted on thisAlan Mateo reacted on thisAfter 6.5 incredible years at Instructure, I’m excited to share that I’m starting my next chapter at SchoolAI 🚀 Instructure has been foundational to my career. I had the privilege of working alongside exceptional teammates, innovative administrators and inspiring educators who use Canvas every day to transform student learning. Becoming a Customer Success Manager right as COVID hit was one of the most defining experiences of my career. Supporting institutions through rapid change gave me a front-row seat to our customers’ evolving needs. Insight that became invaluable when I later transitioned into sales and could advocate for institutions with real perspective. I’m especially grateful to Casey Sato, Jane H., Melissa Loble and Edwin Morales for their mentorship and belief in me. You truly shaped my journey. Now, I’m thrilled to join SchoolAI, where we’re helping institutions thoughtfully and safely integrate AI into teaching and learning to enhance the student experience. The opportunity to shape how AI impacts Higher Education in responsible, student-centered ways makes me energized to dive head first into this new opportunity! Excited to learn from the best (especially Dionne 'Dee' Bohne!) and build what’s next!
-
Alan Mateo liked thisI'm proud to be recognized among this year's Top Female Leaders by The Healthcare Technology Report. The true celebration, though, is the progress our industry has and continues to make — consistently advancing clinical research that improves access, outcomes, and the patient experience. Here's to continuing to push the envelope and persistently lead with impact. #wcgproudAlan Mateo liked thisWe are thrilled to share that WCG’s very own Stacey Yount and Jill Johnston have been recognized as Top Women Leaders in Healthcare Technology of 2025 by The Healthcare Technology Report. This honor celebrates women driving meaningful progress across healthcare technology — turning innovation into real‑world impact. As Chief Growth Officer, Stacey guides WCG’s long‑term growth strategy across clinical research, and as Chief Innovation Officer, Jill leads innovation and transformation across our services and technology. Congratulations to Stacey and Jill, and to all the women leading the future of healthcare technology. Learn more about the award and this year’s honorees at https://lnkd.in/gcE5vFdz #WomenLeaders #HealthTech #Leadership
-
Alan Mateo liked thisAlan Mateo liked thisAnother milestone worth sharing: we were named a Health Value Award winner in Pharmacy Benefit Management! 🏆 This recognition belongs to the teams behind the scenes, from clinical to customer care and everyone in between, who are working every day to make the pharmacy benefits experience clearer and more supportive. It's one more step in our effort to challenge the old PBM model and build something better! ✅
-
Alan Mateo liked thisAlan Mateo liked thisLeading the Future of Healthcare Technology! We’re thrilled to announce that Nagaraja Srivatsan has been named among “The Top Healthcare Technology CEOs of 2025” by The Healthcare Technology Report! This prestigious recognition celebrates his visionary leadership, relentless innovation, and unwavering commitment to transforming healthcare through technology. Under his guidance, we’re redefining what’s possible—improving patient outcomes, driving digital transformation, and shaping the future of health. 👏 Join us in congratulating Nagaraja Srivatsan on this incredible achievement and his continued impact on the industry!
-
Alan Mateo liked thisAlan Mateo liked thisEnd-to-end management of a publication requires navigating intricate processes across multiple stakeholders and shifting timelines. It’s not easy, but doing it well is the difference between science shaping clinical practice vs. getting lost in the noise. It’s time to rethink the model. Our new eBook goes deep into the challenges and gaps in current solutions: https://lnkd.in/e-TRcKgp It also gives a sneak peek into our new Vault Medical product — Veeva Publications will lean into the complexity to make scientific publishing more efficient, intuitive, and connected with the rest of the medical affairs ecosystem. Message me if you’re interested in updates on product availability or just to share your thoughts. #medicalaffairs #pharmaceuticals #publications #medcomms
-
Alan Mateo reacted on thisI’m excited to be joining BillingPlatform as CEO. Over the years, I’ve admired what this team has built. As business models become more complex, BillingPlatform’s flexible, AI-powered monetization platform is helping enterprises scale with confidence, supported by strong execution, blue-chip customers, and consistent analyst recognition. I’m grateful to Dennis Wall for his leadership in building such a strong foundation and pleased that he will remain engaged as a member of the Board. The opportunity ahead is meaningful, and I’m energized to work alongside this team as we continue to scale the businessAlan Mateo reacted on thisWe’re excited to announce that Chris Bishop has been appointed as our new Chief Executive Officer. With a passion for revenue operations, Bishop brings more than 20 years of experience in enterprise software and a proven track record of driving operational scale and business growth. With his strong vision for growth, innovation, and impact, we’re excited for what the future holds! “As evidenced by BillingPlatform’s blue-chip customer base and analyst recognition, the team has built the industry’s most advanced monetization solution. I would like to thank Dennis for his leadership, and I look forward to advancing the mission he championed over the years by continuing to scale operations and accelerating growth worldwide,” said Chris Bishop, CEO at BillingPlatform. Bishop succeeds Dennis Wall, who will remain engaged with the company as a member of its Board of Directors. Please join us in welcoming Chris as we begin this next chapter at BillingPlatform! Read the full release here: https://lnkd.in/gRrEyzEN
-
Alan Mateo liked thisAlan Mateo liked thisThis week we have a very special and exciting episode of #AstonishingHealthcare! We invited three former interns - Jakob Deel, Lisa Y., and Bryan SebaRaj into the studio, all of whom went on to take full-time roles with Judi Health, to discuss their experiences, perspectives on #healthtech, and solutions for advancing #healthcare! As Jakob explained, he'd tell his younger self that while technical skills are important, it's just as valuable to understand the field you're entering, whether that's healthcare or something else. 🎧 Listen to the full episode here: https://okt.to/tFXUjv
-
Alan Mateo liked thisAlan Mateo liked thisJust back from the @JPMorgan Healthcare Conference in San Francisco. An excellent week engaging with a broad range of leaders across tech & science on everything from the "lab of the future" to accelerating and de-risking clinical trials with AI. A highlight: a morning session hosted by @Microsoft where @Alexandra Goncalves, BMS VP Digital Health, shared examples of how digital health technology can change outcomes for patients in safety and non-small cell lung cancer. It’s energizing to be part of a team that puts patients at the center of our work #OneBMS#ProudtobeBMS
-
Alan Mateo liked thisAlan Mateo liked thisExcited to be returning to J.P. Morgan as Global Chair of Investment Banking. I’m looking forward to working with the incredible @J.P. Morgan team on a world class platform to advise our healthcare clients as they growth and innovate across this dynamic sector. https://lnkd.in/gMGqRm_xJPMorgan Hires Health Exec Kosaraju as Investment Banking ChairJPMorgan Hires Health Exec Kosaraju as Investment Banking Chair
View Alan’s full profile
-
See who you know in common
-
Get introduced
-
Contact Alan directly
Other similar profiles
Explore more posts
-
Eva Danieli
MMIT (Managed Markets Insight… • 4K followers
When the industry talks global R&D shifts, it turns to Citeline data: https://vist.ly/4qwhi PharmaVoice recently referenced insights from Citeline’s 2025 Annual Clinical Trials Roundup, noting that Jiangsu Hengrui Pharmaceuticals rose to become the world’s top clinical trial sponsor — underscoring China’s growing role in biopharma innovation. Read the full article: https://vist.ly/4qwhi
4
-
Veeva Systems
302K followers
Hear how top biopharma leaders, Bristol Myers Squibb, Lundbeck, and Pfizer are using Veeva Link Key People data to unlock new insights, improve engagement, and increase efficiencies across commercial and medical. From personalizing engagements and optimizing territories, to accelerating R&D through “horizon scanning,” each of these leaders shares how they’re connecting data to drive real impact. Read the full article: https://lnkd.in/gSzhMs7S #Biopharma #KOLengagement #medicalaffairs #lifesciences
39
-
L.E.K. Consulting
317K followers
Biopharma go-to-market (GTM) planning today demands a new level of precision and flexibility. Peter Rosenorn and Max Cambras explain that leaders should anchor their GTM strategy in data, work cross-functionally, measure performance against prespecified outcomes-based KPIs and recalibrate as needed to ensure the strategy remains targeted and effective. Read the full insights here: https://bit.ly/3WImCI5 #Biopharma #Pharma #LifeSciences #HealthcareIndustry #PatientCare #GoToMarket #Healthcare #GTM
10
1 Comment -
Pharmaceutical Executive
29K followers
💡 What drives drug launch pricing—and how can leaders prepare for the challenges ahead? Jason O’Neill, author of The Secrets of Successful Drug Launches and former Dendreon CEO, unpacks the competitive pressures, market dynamics, and growth opportunities shaping pharma’s future. Watch the full episode here: https://hubs.li/Q03Llq5w0
4
-
Stacie Alexander
2K followers
I’m pleased to share that Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research. This strategic combination enhances our ability to serve customers by adding Catalyst's expertise and innovative FSP model to Worldwide's established therapeutic leadership. Together, we're creating broader capabilities and more flexible service options - all designed to help sponsors bring therapies to patients faster. Both organizations share a people-first culture and commitment to exceptional customer service. We're excited about the opportunities this creates for our customers, our teams, and the patients who will benefit from more efficient clinical research. Read more: https://bit.ly/4qx2O7W
25
-
M. Andrew Fuchs
Veeva Systems • 2K followers
Matt Farrell and Arno Sosna are walking through the latest Vault CRM innovations, including the new AI agents and the Windows App, available in the December release. Highly recommend tuning in to learn more about the next generation CRM Suite for life sciences. https://lnkd.in/ecQziyVy
27
-
SCORR Marketing
5K followers
What happens when commercial strategy starts with science, not just sales? In this SCORRCAST episode, Derek Gooderham of Allumiqs shares how connecting data, internal alignment, and storytelling helps life sciences organizations deliver more value and better results. Listen now: https://lnkd.in/gukjwmDF
12
2 Comments -
David Alderman
Molekule Consulting LLC • 20K followers
Why does Salesforce AI work while biopharma CI AI doesn't? Because Salesforce has something your CI vendor never built: data gravity. 🔹 93% accuracy AI now handles over 40% of Salesforce's workload, says CEO Marc Benioff [CNBC, 2025.06.26]. And he can prove it with real workflows, native metadata, and outcome-tethered feedback loops. Now compare that to biopharma CI AI: 📉 What it runs on: Scraped sentiment Stale PDFs Last year's pipeline decks Secondhand assumptions No HUMINT. No ground truth. No telemetry. Just predictive noise, dressed up as strategy. The result? It feels smart. But it isn't strategic. It's sophisticated autofill: impressive on demo, misaligned in reality. 🧠 The problem isn't the model. It's the inputs. The signal quality. The source proximity. The missing truth layer. The solution isn't more AI. It's better inputs. Verified intelligence. Real conversations. Human context. 📡 At Molekule Consulting, we don't automate desk research. We deliver decision-grade HUMINT from thousands of verified sources built to shape real outcomes, not just summarize them. Because in CI, your edge isn't who automates faster. It's who knows what's real. 🔗 https://lnkd.in/e8uKaXP3 #CompetitiveIntelligence #HUMINT #PharmaAI #BiotechStrategy #MolekuleMethod https://lnkd.in/gECDg8yY
9
-
Domenico Callipari
Saama • 2K followers
AI’s potential in life sciences is massive, but too many projects stall before showing ROI. In this webinar, Saama’s experts unpack why — and show how Agentic AI is changing the game for clinical development. A must-watch for anyone driving innovation in healthcare!
14
-
Pharma Focus America
2K followers
Unlock the 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 with insights from Kean Woodmansey, Senior Product Manager, Echo® MS+. The Echo® MS+ system combined with the ZenoTOF 7600 system leverages acoustic ejection mass spectrometry to transform drug discovery workflows. This platform accelerates assay turnaround times, optimizes buffer conditions, integrates seamlessly with automation, and advances data processing—all while maintaining exceptional analytical quality across diverse applications. For decision-makers and researchers aiming to enhance biomarker quantitation and expedite therapeutic development, this technology offers an unmatched balance of speed and precision. 𝑬𝒙𝒑𝒍𝒐𝒓𝒆 𝒉𝒐𝒘 𝒚𝒐𝒖𝒓 𝒍𝒂𝒃 𝒄𝒂𝒏 𝒃𝒆𝒏𝒆𝒇𝒊𝒕 𝒇𝒓𝒐𝒎 𝒕𝒉𝒊𝒔 𝒕𝒓𝒂𝒏𝒔𝒇𝒐𝒓𝒎𝒂𝒕𝒊𝒗𝒆 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 𝒕𝒐𝒅𝒂𝒚. 🔗 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐦𝐨𝐫𝐞: https://lnkd.in/gcm3zk-8 #BiomarkerDiscovery #MassSpectrometry #DrugDiscovery #PharmaceuticalResearch #HighThroughputScreening #LabelFreeAnalysis #AutomationInPharma #ProteinQuantitation #PeptideAnalysis #DataDrivenDecisions #AnalyticalChemistry #PharmaInnovation #ZenoTOF7600 #EchoMSPlus #TherapeuticDevelopment
6
-
ClinFocus
14K followers
Let’s talk about something that quietly threatens the success of clinical trials: protocol deviations. This document explores how ClinFocus, together with Medidata Solutions, helps clinical research teams detect, track, and address protocol deviations early, before they escalate using real-time validation, automated alerts, and proactive data oversight. If you’re involved in clinical trials, this is a conversation worth having: it’s not just about collecting data it’s about ensuring the integrity of that data from start to finish. For questions or more information please contact us at info@clinfocus.com #ClinicalResearch #DataIntegrity #EDC #Medidata #ProtocolDeviation #ClinicalTrials
55
10 Comments -
Jimmy Bechtel, MBA
Society for Clinical Research… • 12K followers
Veeva's VP of Strategy, Bree Burks, reveals the strategic vision behind their groundbreaking free CTMS platform—a bold move designed to democratize technology access for clinical research sites of all sizes. Discover why Veeva prioritizes site success through standardization and simplicity, and how selecting the right technology partnerships can empower sites to scale operations and thrive ⇢ https://lnkd.in/ehg5PNgV
37
-
Molekule Consulting
19K followers
🧭 The Portability Principle: You've already lost the argument. Not because the data is wrong, but because your idea is too heavy to travel. In the battle for executive mindshare, the lightest idea wins. [𝗟𝗢𝗪 𝗣𝗢𝗥𝗧𝗔𝗕𝗜𝗟𝗜𝗧𝗬] “Our Q3 analysis suggests a market shift towards prioritizing operational efficiency...” ⇓ ⚡ 𝗗𝗜𝗦𝗧𝗜𝗟𝗟 [𝗛𝗜𝗚𝗛 𝗣𝗢𝗥𝗧𝗔𝗕𝗜𝗟𝗜𝗧𝗬] “The market does not buy products. It buys outcomes.” You cannot bring a 30-page deck to a knife fight. 𝘛𝘩𝘦 𝘨𝘰𝘢𝘭 𝘪𝘴𝘯'𝘵 𝘫𝘶𝘴𝘵 𝘵𝘰 𝘣𝘦 𝘳𝘪𝘨𝘩𝘵. 𝘐𝘵'𝘴 𝘵𝘰 𝘣𝘦 𝘳𝘦𝘱𝘦𝘢𝘵𝘦𝘥. #Business #Strategy #Marketing #Communication #Leadership
3
-
Melissa Roberts Chapman
KC BioHub • 6K followers
Over the past week, the KC BioHub page has started sharing information about a few members of the massive cluster of bioservices businesses (CROs, CDMOs, Regulatory Affairs and Reg CMC firms) that are located in the KC region. After the passage of the BioSecure Act provisions in the previous NDAA, and more conversations about the bioeconomy happening every day in Washington, it's time to start paying attention to where the action is, domestically. Biotechs are starting to consider not just how reliably, how fast, or how expertly bioservices firms do their work. They're starting to care WHERE they are, too. If you're looking for full-spectrum capability in a domestic market that is full of established, expert partners, Kansas City needs to be on your short list for site visits. Eurofins Viracor BioPharma Services is first up, and we'll be highlighting more firms in the coming weeks. If you're wondering what companies are driving the growth of the bioeconomy in our region, now is a great time to give both the KC BioHub and Eurofins a follow! (And while you're at it, follow AdAstra BIO and Missouri Biotechnology Association (MOBIO), our state trade associations, too.)
39
-
Inside the Blueprint
2K followers
🧪 AI meets innovation in clinical trials. This weekend on Inside the Blueprint, we’re spotlighting Medidata Solutions, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry. With a secure, global cloud platform and data analytics tools supporting over 36,000 trials, Medidata is helping biopharma companies bring life-changing therapies to market faster, safer, and smarter. Don’t miss their segment: ▶️ Saturday, 11/22 at 4:30 PM ET on Fox Business ▶️ Sunday, 11/23 at 2:30 PM ET on Bloomberg US #InsideTheBlueprint #Medidata #AIinHealthcare #ClinicalTrials #DigitalInnovation #LifeSciences
30
1 Comment -
Koneksa
12K followers
Newly formalized. Long-established execution. We're proud to announce our partnership with Medidata Solutions and bring measurement-first thinking into the platform many sponsors know and trust. Our team brings years of experience operating within Medidata environments. Now, we’re integrating that execution depth with a measurement-science lens to clarify treatment effects and support stronger clinical decisions. Learn more about Koneksa and the exciting things we're doing with Medidata at #MedidataNext: https://lnkd.in/emBmRacf
24
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content